Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Food addiction and impaired executive functions in women with obesity

  • Steward, Trevor|||0000-0003-3116-8175
  • Mestre-Bach, Gemma|||0000-0001-5345-0484
  • Vintró Alcaraz, Cristina|||0000-0001-9453-8810
  • Lozano Madrid, María|||0000-0003-3833-317X
  • Agüera, Zaida|||0000-0003-4453-4939
  • Fernandez Formoso, Jose Antonio|||0000-0001-5310-1655
  • Granero, Roser|||0000-0001-6308-3198
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • García Ruiz de Gordejuela, Amador|||0000-0002-0485-8536
  • Veciana de las Heras, Misericordia|||0000-0002-1878-8663
  • Custal, Nuria
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Gearhardt, Ashley N.|||0000-0003-3843-5731
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Background: Individuals with obesity (OB) often report suffering from addiction-like symptoms. As in addictions, deficits in executive function domains, such as decision-making and sustained attention, are found in OB. No study to date has examined the associations between food addiction, OB, and neuropsychological performance. Method: Thirty-three adult women with OB and 36 healthy weight controls completed the Yale Food Addiction Scale Version 2.0, a validated instrument used to assess food-related addictive behaviours. Additionally, participants completed computerized versions of the Iowa Gambling Task (IGT) and Conners' Continuous Performance Test, second edition (CPT-II) to examine decision-making and attentional control, respectively. Results: Food addiction criteria were met in 24.2% of the participants with OB and in 2.8% of the control group. In the OB group, food addiction severity levels were negatively correlated with overall scores on the IGT. Participants with OB meeting criteria for food addiction committed more omissions and perseveration errors on the CPT-II compared with those without food addiction. Conclusions: Our results point to an association between food addiction severity levels and impairments in decision-making and attentional capacity in individuals with OB. Given the heterogeneity found in OB, it stands to reason that this subset of patients with food addiction could potentially benefit from interventions targeting neuropsychological deficits.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The neural correlates of obsessive-compulsive disorder, a multimodal perspective

  • Moreira, Pedro
  • Marques, P.
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Magalhães, R.
  • Sousa, N.|||0000-0002-8755-5126
  • Soares, J. M.
  • Morgado, Pedro|||0000-0003-3880-3258
Obsessive-compulsive disorder (OCD) is one of the most debilitating psychiatric conditions. An extensive body of the literature has described some of the neurobiological mechanisms underlying the core manifestations of the disorder. Nevertheless, most reports have focused on individual modalities of structural/functional brain alterations, mainly through targeted approaches, thus possibly precluding the power of unbiased exploratory approaches. Eighty subjects (40 OCD and 40 healthy controls) participated in a multimodal magnetic resonance imaging (MRI) investigation, integrating structural and functional data. Voxel-based morphometry analysis was conducted to compare between-group volumetric differences. The whole-brain functional connectome, derived from resting-state functional connectivity (FC), was analyzed with the network-based statistic methodology. Results from structural and functional analysis were integrated in mediation models. OCD patients revealed volumetric reductions in the right superior temporal sulcus. Patients had significantly decreased FC in two distinct subnetworks: the first, involving the orbitofrontal cortex, temporal poles and the subgenual anterior cingulate cortex; the second, comprising the lingual and postcentral gyri. On the opposite, a network formed by connections between thalamic and occipital regions had significantly increased FC in patients. Integrative models revealed direct and indirect associations between volumetric alterations and FC networks. This study suggests that OCD patients display alterations in brain structure and FC, involving complex networks of brain regions. Furthermore, we provided evidence for direct and indirect associations between structural and functional alterations representing complex patterns of interactions between separate brain regions, which may be of upmost relevance for explaining the pathophysiology of the disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users

  • Batalla, Albert|||0000-0002-5010-5121
  • Lorenzetti, Valentina|||0000-0002-5917-7068
  • Chye, Yann
  • Yücel, Murat|||0000-0002-4705-452X
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Bhattacharyya, Sagnik
  • Torrens, Marta
  • Crippa, José A. S.
  • Martín Santos, Rocío
Introduction: Hippocampal neuroanatomy is affected by genetic variations in dopaminergic candidate genes and environmental insults, such as early onset of chronic cannabis exposure. Here, we examine how hippocampal total and subregional volumes are affected by cannabis use and functional polymorphisms of dopamine-relevant genes, including the catechol-O-methyltransferase (COMT), dopamine transporter (DAT1), and the brain-derived neurotrophic factor (BDNF) genes. Material and Methods: We manually traced total hippocampal volumes and automatically segmented hippocampal subregions using high-resolution MRI images, and performed COMT, DAT1, and BDNF genotyping in 59 male Caucasian young adults aged 18-30 years. These included 30 chronic cannabis users with early-onset (regular use at <16 years) and 29 age-, education-, and intelligence-matched controls. Results: Cannabis use and dopaminergic gene polymorphism had both distinct and interactive effects on the hippocampus. We found emerging alterations of hippocampal total and specific subregional volumes in cannabis users relative to controls (i.e., CA1, CA2/3, and CA4), and associations between cannabis use levels and total and specific subregional volumes. Furthermore, total hippocampal volume and the fissure subregion were affected by cannabis×DAT1 polymorphism (i.e., 9/9R and in 10/10R alleles), reflecting high and low levels of dopamine availability. Conclusion: These findings suggest that cannabis exposure alters the normal relationship between DAT1 polymorphism and the anatomy of total and subregional hippocampal volumes, and that specific hippocampal subregions may be particularly affected.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BDNF genetic variants and methylation, effects on cognition in major depressive disorder

  • Ferrer, Alex|||0000-0002-3040-1177
  • Labad, Javier|||0000-0003-2214-1886
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Barrachina, Marta
  • Costas, Javier|||0000-0003-0306-3990
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Crespo, José M.
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
Brain-derived neurotrophic factor (BDNF) gene regulation has been linked to the pathophysiology of major depressive disorder (MDD). MDD patients show cognitive deficits, and altered BDNF regulation has a relevant role in neurocognitive functions. Our goal was to explore the association between BDNF genetic and epigenetic variations with neurocognitive performance in a group of MDD patients and healthy controls considering possible modulating factors. The sample included 134 subjects, 64 MDD patients, and 70 healthy controls. Clinical data, childhood maltreatment, and neurocognitive performance were assessed in all participants. Eleven single nucleotide polymorphisms (SNPs) and two promoter regions in the BDNF gene were selected for genotype and methylation analysis. The role of interactions between BDNF genetic and epigenetic variations with MDD diagnosis, sex, and Childhood Trauma Questionnaire (CTQ) scores was also explored. We observed significant associations between neurocognitive performance and two BDNF SNPs (rs908867 and rs925946), an effect that was significantly mediated by methylation values at specific promoter I sites. We identified significant associations between neurocognitive results and methylation status as well as its interactions with MDD diagnosis, sex, and CTQ scores. Our results support the hypothesis that BDNF gene SNPs and methylation status, as well as their interactions with modulating factors, can influence cognition. Further studies are required to confirm the effect of BDNF variations and cognitive function in larger samples.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group, The power of worldwide collaboration

  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • Boedhoe, Premika
  • Bertolín Triquell, Sara|||0000-0003-1468-7862
  • Bruin, Willem Benjamin|||0000-0002-0672-8903
  • Francks, Clyde|||0000-0002-9098-890X
  • Ivanov, Iliyan
  • Jahanshad, Neda|||0000-0003-4401-8950
  • Kong, Xiang-Zhen|||0000-0002-0805-1350
  • Kwon, Jun Soo|||0000-0002-1060-1462
  • O'Neill, Joseph
  • Paus, Tomas|||0000-0003-1495-9338
  • Patel, Yash
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Schmaal, Lianne|||0000-0001-9822-048X
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • van Wingen, Guido|||0000-0003-3076-5891
  • Yun, Je-Yeon|||0000-0002-5531-2410
  • Vriend, Chris|||0000-0003-3111-1304
  • Simpson, H. Blair
  • van Rooij, Daan
  • Hoexter, Marcelo Q.
  • Hoogman, Martine|||0000-0002-1261-7628
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Beucke, Jan C.
  • Benedetti, Francesco|||0000-0003-4949-856X
  • Bollettini, Irene|||0000-0003-3666-3538
  • Bose, Anushree|||0000-0002-3394-1646
  • Brennan, Brian P.|||0000-0001-5468-6552
  • De Nadai, Alessandro S.
  • Fitzgerald, Kate
  • Gruner, Patricia
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Hirano, Yoshiyuki|||0000-0003-3844-3061
  • Huyser, Chaim|||0000-0001-8757-3124
  • James, Anthony|||0000-0002-2742-8328
  • Koch, Kathrin|||0000-0003-4664-8016
  • Kvale, Gerd|||0000-0001-5449-2344
  • Lázaro, Luisa|||0000-0002-8425-5750
  • Lochner, Christine|||0000-0002-4766-3704
  • Marsh, Rachel|||0000-0003-2439-6305
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Morgado, Pedro|||0000-0003-3880-3258
  • Nakamae, Takashi|||0000-0003-4265-198X
  • Nakao, Tomohiro
  • Narayanaswamy, Janardhanan C.
  • Nurmi, Erika
  • Pittenger, Christopher|||0000-0003-2117-9321
  • Reddy, Y. C. Janardhan
  • Sato, João R.
  • Soreni, Noam
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Taylor, Stephan F.
  • Tolin, David
  • Thomopoulos, Sophia I.|||0000-0002-0046-4070
  • Veltman, Dick J.
  • Venkatasubramanian, Ganesan|||0000-0002-0949-898X
  • Walitza, Susanne|||0000-0002-8161-8683
  • Wang, Zhen|||0000-0003-4319-5314
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Stein, Dan J.|||0000-0001-7218-7810
Neuroimaging has played an important part in advancing our understanding of the neurobiology of obsessive-compulsive disorder (OCD). At the same time, neuroimaging studies of OCD have had notable limitations, including reliance on relatively small samples. International collaborative efforts to increase statistical power by combining samples from across sites have been bolstered by the ENIGMA consortium; this provides specific technical expertise for conducting multi-site analyses, as well as access to a collaborative community of neuroimaging scientists. In this article, we outline the background to, development of, and initial findings from ENIGMA's OCD working group, which currently consists of 47 samples from 34 institutes in 15 countries on 5 continents, with a total sample of 2,323 OCD patients and 2,325 healthy controls. Initial work has focused on studies of cortical thickness and subcortical volumes, structural connectivity, and brain lateralization in children, adolescents and adults with OCD, also including the study on the commonalities and distinctions across different neurodevelopment disorders. Additional work is ongoing, employing machine learning techniques. Findings to date have contributed to the development of neurobiological models of OCD, have provided an important model of global scientific collaboration, and have had a number of clinical implications. Importantly, our work has shed new light on questions about whether structural and functional alterations found in OCD reflect neurodevelopmental changes, effects of the disease process, or medication impacts. We conclude with a summary of ongoing work by ENIGMA-OCD, and a consideration of future directions for neuroimaging research on OCD within and beyond ENIGMA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium, medication matters

  • Bruin, Willem Benjamin|||0000-0002-0672-8903
  • Taylor, Luke
  • Thomas, Rajat M.
  • Shock, Jonathan P.|||0000-0003-3757-0376
  • Zhutovsky, Paul|||0000-0003-3737-6258
  • Abe, Yoshinari|||0000-0001-8348-0801
  • Alonso, Pino|||0000-0002-5779-9111
  • Ameis, Stephanie H.|||0000-0002-7282-6077
  • Anticevic, Alan
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Assogna, Francesca
  • Benedetti, Francesco|||0000-0003-4949-856X
  • Beucke, Jan C.
  • Boedhoe, Premika
  • Bollettini, Irene|||0000-0003-3666-3538
  • Bose, Anushree|||0000-0002-3394-1646
  • Brem, Silvia
  • Brennan, Brian P.|||0000-0001-5468-6552
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Calvo-Escalona, Rosa|||0000-0001-9572-4228
  • Cheng, Yuqi
  • Cho, Kang Ik K.
  • Dallaspezia, Sara
  • Denys, Damiaan|||0000-0002-3191-3844
  • Ely, Benjamin A.|||0000-0002-3019-0090
  • Feusner, Jamie D.
  • Fitzgerald, Kate D.
  • Fouche, Jean-Paul|||0000-0002-0830-2324
  • Fridgeirsson, Egill A.
  • Gruner, Patricia
  • Gürsel, Deniz A.
  • Hauser, Tobias U.|||0000-0002-7997-8137
  • Hirano, Yoshiyuki|||0000-0003-3844-3061
  • Hoexter, Marcelo Q.
  • Hu, Hao
  • Huyser, Chaim|||0000-0001-8757-3124
  • Ivanov, Iliyan
  • James, Anthony|||0000-0002-2742-8328
  • Jaspers-Fayer, Fern
  • Kathmann, Norbert|||0000-0002-1348-7060
  • Kaufmann, Christian
  • Koch, Kathrin|||0000-0003-4664-8016
  • Kuno, Masaru
  • Kvale, Gerd|||0000-0001-5449-2344
  • Kwon, Jun Soo|||0000-0002-1060-1462
  • Liu, Yanni
  • Lochner, Christine|||0000-0002-4766-3704
  • Lázaro, Luisa|||0000-0002-8425-5750
  • Marques, Paulo
  • Marsh, Rachel|||0000-0003-2439-6305
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Minuzzi, Luciano
  • Moreira, Pedro S.
  • Morer, Astrid
  • Morgado, Pedro|||0000-0003-3880-3258
  • Nakagawa, Akiko
  • Nakamae, Takashi|||0000-0003-4265-198X
  • Nakao, Tomohiro
  • Narayanaswamy, Janardhanan C.
  • Nurmi, Erika L.|||0000-0003-4893-8957
  • O'Neill, Joseph
  • Pariente, Jose C.
  • Perriello, Chris
  • Piacentini, John|||0000-0003-4195-7194
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Piras, Federica|||0000-0002-9546-7038
  • Reddy, Y. C. Janardhan
  • Rus-Oswald, Oana G.|||0000-0003-2952-5583
  • Sakai, Yuki|||0000-0003-2475-8548
  • Sato, João R.
  • Schmaal, Lianne|||0000-0001-9822-048X
  • Shimizu, Eiji
  • Simpson, H. Blair
  • Soreni, Noam
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stern, Emily R.
  • Stevens, Michael C.|||0000-0002-3799-5465
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Szeszko, Philip R.
  • Tolin, David F.
  • Venkatasubramanian, Ganesan|||0000-0002-0949-898X
  • Wang, Zhen|||0000-0003-4319-5314
  • Yun, Je-Yeon|||0000-0002-5531-2410
  • van Rooij, Daan
  • Thompson, Paul M.|||0000-0002-4720-8867
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • Stein, Dan J.|||0000-0001-7218-7810
  • van Wingen, Guido|||0000-0003-3076-5891
No diagnostic biomarkers are available for obsessive-compulsive disorder (OCD). Here, we aimed to identify magnetic resonance imaging (MRI) biomarkers for OCD, using 46 data sets with 2304 OCD patients and 2068 healthy controls from the ENIGMA consortium. We performed machine learning analysis of regional measures of cortical thickness, surface area and subcortical volume and tested classification performance using cross-validation. Classification performance for OCD vs. controls using the complete sample with different classifiers and cross-validation strategies was poor. When models were validated on data from other sites, model performance did not exceed chance-level. In contrast, fair classification performance was achieved when patients were grouped according to their medication status. These results indicate that medication use is associated with substantial differences in brain anatomy that are widely distributed, and indicate that clinical heterogeneity contributes to the poor performance of structural MRI as a disease marker.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lower Locus Coeruleus MRI intensity in patients with late-life major depression

  • Guinea-Izquierdo, Andrés
  • Giménez, Mónica|||0000-0003-2757-0145
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • del Cerro, Inés
  • Canal-Noguer, Pol
  • Blasco, Gerard|||0000-0002-5302-0625
  • Gascón, Jordi
  • Reñé, Ramon
  • Rico, Inmaculada
  • Camins, Àngels|||0000-0003-2678-8134
  • Aguilera, Carlos
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
  • Soriano-Mas, Carles|||0000-0003-4574-6597
The locus coeruleus (LC) is the major noradrenergic source in the central nervous system. Structural alterations in the LC contribute to the pathophysiology of different neuropsychiatric disorders, which may increase to a variable extent the likelihood of developing neurodegenerative conditions. The characterization of such alterations may therefore help to predict progression to neurodegenerative disorders. Despite the LC cannot be visualized with conventional magnetic resonance imaging (MRI), specific MRI sequences have been developed to infer its structural integrity. We quantified LC signal Contrast Ratios (LCCRs) in late-life major depressive disorder (MDD) (n = 37, 9 with comorbid aMCI), amnestic Mild Cognitive Impairment (aMCI) (n = 21, without comorbid MDD), and healthy controls (HCs) (n = 31), and also assessed the putative modulatory effects of comorbidities and other clinical variables. LCCRs were lower in MDD compared to aMCI and HCs. While no effects of aMCI comorbidity were observed, lower LCCRs were specifically observed in patients taking serotonin/norepinephrine reuptake inhibitors (SNRIs). Our results do not support the hypothesis that lower LCCRs characterize the different clinical groups that may eventually develop a neurodegenerative disorder. Conversely, our results were specifically observed in patients with late-life MDD taking SNRIs. Further research with larger samples is warranted to ascertain whether medication or particular clinical features of patients taking SNRIs are associated with changes in LC neurons.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection

  • Prats, Anna|||0000-0002-3586-4525
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Garolera, Maite
  • Domenech, Sira|||0000-0002-5700-768X
  • Coll, Pep
  • Meulbroek, Michael
  • Chamorro, Anna
  • Fumaz, Carmina R.|||0000-0003-0838-3395
  • Ferrer, Maria Jose
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Muñoz-Moreno, José Antonio|||0000-0002-7239-5422
Integrase strand transfer inhibitors (INSTI) are a main component of the current antiretroviral regimens recommended for treatment of HIV infection. However, little is known about the impact of INSTI on neurocognition and neuroimaging. We developed a prospective observational trial to evaluate the effects of INSTI-based antiretroviral therapy on comprehensive brain outcomes (cognitive, functional, and imaging) according to the time since HIV-1 acquisition. We recruited men living with HIV who initiated antiretroviral therapy with INSTI < 3 months since the estimated date of HIV-1 acquisition (n = 12) and.